Reveal Biosciences Inc.

UEI
HEEAZ9FXXM13
CAGE
6TK86
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
cellcarta.com
Founded
2000
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$1,980
FY2024 $0
FY2023 -$27,161

Contract awards

Award Agency Obligated Awarded
Antibody procurement/h & e (tissue to imaging, no analysis)/ massons trichrome (blocks to imaging, no analysis)/ plex… N0025922P0201 Bureau of Medicine and Surgery (Navy) $30,420
Topic #411 - phase i sbir contract - an imagedx based platform for comprehensive DE-identification of WSI data 75N91020C00026 National Cancer Institute (NIH) $370,804
Sbir phase i topic 402: artificial intelligence-aided imaging for cancer prevention, diagnosis, and monitoring 75N91020C00051 National Cancer Institute (NIH) $392,343
Sbir solicitation no. PHS 2020-1 topic #408: tools and technologies for visualizing multi-scale data project title… 75N91020C00012 National Cancer Institute (NIH) $386,940
ENT department research team requires a lab that can perform immunohistochemistry stain with antibodies to collagen i… N0025919P0244 Bureau of Medicine and Surgery (Navy) $13,545

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Proscia Inc. UEI ERA4KB1T3EP7 — 513210 Software Publishers
Surgivance Inc. UEI JH4EDZ5CQZD5 New York, NY —
Vizlitics Inc. UEI N1EMHHVX3F35 Chappaqua, NY 513210 Software Publishers
Alpenglow Biosciences, Inc. UEI DVN2AF9A1YV3 Seattle, WA 621511 Medical Laboratories
Histowiz, Inc. UEI J9LMK25NKRM6 NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Reveal Biosciences Inc. is a computational pathology company that provides advanced tissue analysis technologies and artificial intelligence-enabled imaging platforms for cancer research and diagnosis. The company combines traditional histopathology with AI to transform tissue into actionable data.

Reveal Biosciences has been awarded multiple federal contracts from HHS agencies like NIH and NCI to develop AI and imaging platforms to support cancer research and prevention efforts. This includes SBIR contracts to build tools for visualizing multi-scale cancer data across tissue, cellular, molecular, and genomic levels. Reveal has also received contracts for comprehensive de-identification of whole slide imaging data to enable broader research use, as well as for novel AI-aided imaging approaches for cancer screening and monitoring. Additionally, Reveal has provided specialized immunohistochemistry services for Navy medical research. The contract awards have generally been firm-fixed price vehicles with Reveal Biosciences as the prime contractor. Most have involved total small business set-asides.

Quick answers

Is Reveal Biosciences Inc. registered in SAM.gov?

Reveal Biosciences Inc.'s SAM.gov registration expired on July 23, 2024.

What is Reveal Biosciences Inc.'s most recent federal award?

Reveal Biosciences Inc.'s most recent federal contract award is Antibody procurement/h & e (tissue to imaging, no analysis)/ massons trichrome (blocks to imaging, no analysis)/ plex… (N0025922P0201), from Bureau of Medicine and Surgery (Navy), on July 13, 2022.

On GovTribe

See Reveal Biosciences Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login